Warren C. Lau
Gründer bei NEXUS BIOPHARMA, INC.
Profil
Warren C.
Lau was the founder of Mast Therapeutics, Inc. (founded in 1996) where he served as President, Chief Executive Officer & Director from 1996 to 2001.
He was also the founder of HoustonPharma, Inc. (founded in 2005) where he held the position of President & Chief Executive Officer from 2005 to 2008.
In 2007, he founded Nexus Biopharma, Inc. and currently holds the position of President, Chief Executive Officer & Director.
Mr. Lau founded PharmaFrontiers Corp.
in 2003 and served as President & Chief Executive Officer from 2003 to 2004.
In 2009, he founded MetaStat, Inc. and held the positions of President, Chief Financial Officer & Director from 2012 to 2014.
Mr. Lau is also the founder of Transchem, Inc. Mr. Lau's former job positions include President, Chief Executive Officer & Director at Photovoltaic Solar Cells, Inc. in 2012, President, Chief Executive Officer & Director at Opexa Therapeutics, Inc., President, Chief Executive Officer & Director at Nexus BioPharma Corp.
from 2009 to 2015, Director at Immune Complex Corp.
in 1998, Director at Synthetic Genetics in 1998, and Director at YouBlast Global, Inc. Mr. Lau completed his undergraduate degree at Southern Methodist University.
Aktive Positionen von Warren C. Lau
| Unternehmen | Position | Beginn |
|---|---|---|
| NEXUS BIOPHARMA, INC. | Gründer | 17.07.2007 |
Transchem, Inc.
 Transchem, Inc. Wholesale DistributorsDistribution Services Transchem, Inc. supplies various chemicals including solvents such as ethyl hexanol, isophorane, and phosphoric acid. The private company is based in Carlsbad, CA. The company was founded by Warren C. Lau and he has been the CEO since incorporation. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Warren C. Lau
| Unternehmen | Position | Ende |
|---|---|---|
Nexus BioPharma Corp.
 Nexus BioPharma Corp. Pharmaceuticals: MajorHealth Technology Nexus BioPharma Corp. engages in the development of a drug to treat obesity. The firm specializes in obesity and diabetes. The company is headquartered in Montclair, NJ. | Vorstandsvorsitzender | 01.02.2015 |
Photovoltaic Solar Cells, Inc.
 Photovoltaic Solar Cells, Inc. Financial ConglomeratesFinance Photovoltaic Solar Cells, Inc. is a development stage company. It engages in identifying, investigating and if warranted, acquiring companies. The company was founded by Lawrence F. Curtin on March 28, 2007 and is headquartered in New York, NY. | Präsident | 20.04.2012 |
HoustonPharma, Inc.
 HoustonPharma, Inc. Pharmaceuticals: MajorHealth Technology HoustonPharma, Inc. develops pharmaceutical products and technologies. It develops oncolytic virus technologies for the treatment of cancer, including ovarian cancer, glioblastoma, and multiple myeloma. The company is headquartered in Malvern, PA. | Gründer | 01.03.2008 |
| PharmaFrontiers Corp. | Gründer | - |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Gründer | 01.11.2001 |
Ausbildung von Warren C. Lau
| Southern Methodist University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| Private Unternehmen | 11 |
|---|---|
HoustonPharma, Inc.
HoustonPharma, Inc. Pharmaceuticals: MajorHealth Technology HoustonPharma, Inc. develops pharmaceutical products and technologies. It develops oncolytic virus technologies for the treatment of cancer, including ovarian cancer, glioblastoma, and multiple myeloma. The company is headquartered in Malvern, PA. | Health Technology |
| PharmaFrontiers Corp. | Health Technology |
YouBlast Global, Inc.
 YouBlast Global, Inc. Advertising/Marketing ServicesCommercial Services YouBlast Global, Inc. is a development stage company, which develops and operates digital lifestyle portals. The company's principal activities include marketing services to advertisers and publishers, such as display advertising and search advertising, on the company's social publishing network, YouBlast.com, and across its affiliate web properties, such as Honeymag.com; web publishing services to users, such as single-click publishing tools, click to CDN streaming tools, advanced web and file analytics and single click e-commerce tools; enterprise solutions for companies seeking to sub-license and custom-brand YouBlast products and services on a broader scale. It is a one-stop-shop for internet users and businesses to create a rich website with easy to use publishing, analytics and e-commerce tools. YouBlast Global was founded on September 26, 1997 and is headquartered in Miami Beach, FL. | Commercial Services |
Photovoltaic Solar Cells, Inc.
Photovoltaic Solar Cells, Inc. Financial ConglomeratesFinance Photovoltaic Solar Cells, Inc. is a development stage company. It engages in identifying, investigating and if warranted, acquiring companies. The company was founded by Lawrence F. Curtin on March 28, 2007 and is headquartered in New York, NY. | Finance |
| Immune Complex Corp. | Health Technology |
Synthetic Genetics
 Synthetic Genetics Miscellaneous Commercial ServicesCommercial Services Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million. | Commercial Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Nexus BioPharma Corp.
Nexus BioPharma Corp. Pharmaceuticals: MajorHealth Technology Nexus BioPharma Corp. engages in the development of a drug to treat obesity. The firm specializes in obesity and diabetes. The company is headquartered in Montclair, NJ. | Health Technology |
Nexus Biopharma, Inc.
 Nexus Biopharma, Inc. BiotechnologyHealth Technology Nexus Biopharma, Inc. is a preclinical stage biotechnology company, which engages in the research and development of new therapies and intellectual property for treating obesity and type 2 diabetes. The company was founded by Warren C. Lau on July 17, 2007 and is headquartered in Houston. TX. | Health Technology |
Transchem, Inc.
Transchem, Inc. Wholesale DistributorsDistribution Services Transchem, Inc. supplies various chemicals including solvents such as ethyl hexanol, isophorane, and phosphoric acid. The private company is based in Carlsbad, CA. The company was founded by Warren C. Lau and he has been the CEO since incorporation. | Distribution Services |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
